We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-18.56%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.67B
AUM Growth
-$412M
Cap. Flow
+$65.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 39.37%
2 Financials 7.66%
3 Consumer Discretionary 5.31%
4 Communication Services 3.82%
5 Industrials 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBAY
26
DELISTED
Cymabay Therapeutics
CBAY
$6.2M 0.37%
792,096
+328,289
+71% +$3.12M
DB icon
27
Deutsche Bank
DB
$69B
$6.14M 0.37%
793,000
+6,000
+0.8% +$58.6K
ATRC icon
28
AtriCure
ATRC
$1.92B
$5.73M 0.34%
197,459
FOLD
29
DELISTED
Amicus Therapeutics
FOLD
$4.96M 0.3%
533,969
+119,173
+29% +$1.31M
MSFT icon
30
Microsoft
MSFT
$3.45T
$4.95M 0.3%
48,948
-260
-0.5% -$27.9K
BN icon
31
Brookfield
BN
$104B
$4.9M 0.29%
360,151
+37,837
+12% +$565K
INCY icon
32
Incyte
INCY
$24.2B
$4.78M 0.29%
76,610
+27,000
+54% +$1.75M
MA icon
33
Mastercard
MA
$502B
$4.76M 0.28%
25,240
-600
-2% -$119K
TGA
34
DELISTED
Transglobe Energy Corp
TGA
$4.52M 0.27%
2,422,923
BEP icon
35
Brookfield Renewable
BEP
$9.97B
$4.5M 0.27%
187,650
BYSI icon
36
BeyondSpring
BYSI
$47.3M
$4.5M 0.27%
240,000
ALBO
37
DELISTED
Albireo Pharma Inc
ALBO
$4.49M 0.27%
+197,005
New +$5.21M
NBIX icon
38
Neurocrine Biosciences
NBIX
$16.8B
$4.41M 0.26%
62,323
+19,223
+45% +$1.84M
V icon
39
Visa
V
$684B
$4.38M 0.26%
33,190
-3,100
-9% -$428K
BKNG icon
40
Booking.com
BKNG
$149B
$4.1M 0.25%
59,700
+45,325
+315% +$3.32M
APLS
41
DELISTED
Apellis Pharmaceuticals
APLS
$3.91M 0.23%
+294,728
New +$4.52M
XOMA
42
DELISTED
Xoma
XOMA
$3.84M 0.23%
+316,234
New +$4.52M
META icon
43
Meta Platforms (Facebook)
META
$1.42T
$3.74M 0.22%
27,883
-247
-0.9% -$35.8K
JOYY
44
JOYY Inc
JOYY
$3.71B
$3.58M 0.21%
+59,800
New +$3.9M
IMMU
45
DELISTED
Immunomedics Inc
IMMU
$3.58M 0.21%
235,433
+160,000
+212% +$3.18M
IRWD icon
46
Ironwood Pharmaceuticals
IRWD
$696M
$3.36M 0.2%
415,155
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.34M 0.2%
16,700
-21,000
-56% -$4.39M
ALNY icon
48
Alnylam Pharmaceuticals
ALNY
$27.5B
$3.31M 0.2%
48,300
+11,800
+32% +$908K
ASND icon
49
Ascendis Pharma A/S
ASND
$16B
$3.25M 0.19%
53,326
ALXN
50
DELISTED
Alexion Pharmaceuticals
ALXN
$3.23M 0.19%
33,224
-21,000
-39% -$2.48M

Similar funds

Fosun International's Q4 2018 Portfolio in Review

As of Q4 2018, Fosun International held 343 positions worth $1.67B, down 20% from $2.09B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Fosun International deployed $65.2M of net new capital in Q4 2018, opening 97 new positions and adding to 69 existing holdings. Its largest new stake was Albireo Pharma Inc: 197,005 shares worth $4.49M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $57.6M trimmed.

  • Fosun International's largest Q4 2018 buy was Albireo Pharma Inc: 197,005 shares worth $4.49M.
  • Fosun International added most to Seadrill Limited Common Stock in Q4 2018, an estimated $25.6M increase.
  • Fosun International's biggest Q4 2018 reduction was Brookdale Senior Living, cutting an estimated $57.6M.
  • Fosun International fully exited Bilibili in Q4 2018, selling an estimated $13M.
  • Fosun International's ten largest holdings make up 54% of its $1.67B portfolio in Q4 2018.
  • Fosun International opened 97 new positions and closed 44 in Q4 2018.
  • Fosun International's portfolio value fell 20% quarter-over-quarter to $1.67B.

Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.